Edition:
United Kingdom

Reckitt Benckiser Group PLC (RB.L)

RB.L on London Stock Exchange

6,236.00GBp
13 Nov 2018
Change (% chg)

-14.00 (-0.22%)
Prev Close
6,250.00
Open
6,248.00
Day's High
6,292.00
Day's Low
6,189.00
Volume
913,022
Avg. Vol
1,206,042
52-wk High
7,174.00
52-wk Low
5,255.00

Select another date:

Tue, Oct 30 2018

Photo

BP 'blowout' results keep FTSE afloat as Reckitt tumbles

MILAN A strong update from BP helped the UK's top share index end a choppy session in the black on Tuesday, offsetting disappointing results from heavyweight Reckitt Benckiser and outperforming European equities.

UPDATE 1-BP 'blowout' results keep FTSE afloat as Reckitt tumbles

MILAN, Oct 30 A strong update from BP helped the UK's top share index end a choppy session in the black on Tuesday, offsetting disappointing results from heavyweight Reckitt Benckiser and outperforming European equities.

Infant formula growing pains hurt Reckitt Benckiser sales

LONDON A manufacturing glitch at a Dutch factory producing baby milk hurt Reckitt Benckiser's third-quarter sales, the latest in a string of problems to hit the British consumer goods group, this time, in the formula business it bought last year for $17 billion (13.3 billion pounds).

Infant formula growing pains hurt Reckitt Benckiser sales

LONDON A manufacturing glitch at a Dutch factory producing baby milk hurt Reckitt Benckiser's third-quarter sales, the latest in a string of problems to hit the British consumer goods group, this time, in the formula business it bought last year for $17 billion.

UPDATE 4-Infant formula growing pains hurt Reckitt Benckiser sales

* Shares fall 5 percent (Adds details on pricing, rest of business)

BP 'blowout' results keep FTSE afloat as Reckitt tumbles

MILAN, Oct 30 A strong update from BP helped the UK's top share index edge up in morning trade on Tuesday, offsetting disappointing results from heavyweight Reckitt Benckiser and outperforming European equities.

Reckitt Benckiser sales hurt by manufacturing disruption

LONDON, Oct 30 British consumer goods maker Reckitt Benckiser Group said that third-quarter sales growth had been held back by a temporary manufacturing disruption at a European baby formula factory.

U.S. joins lawsuits against Indivior, Reckitt over drug Suboxone

The U.S. Justice Department has joined several whistleblower lawsuits against Indivior Plc and Reckitt Benckiser Group PLC , alleging that the drugmakers improperly marketed the opioid addiction treatment Suboxone.

U.S. joins lawsuits against Indivior, Reckitt over drug Suboxone

The U.S. Justice Department has joined several whistleblower lawsuits against Indivior Plc and Reckitt Benckiser Group PLC, alleging that the drugmakers improperly marketed the opioid addiction treatment Suboxone.

U.S. joins lawsuits against Indivior, Reckitt over drug Suboxone

Aug 8 The U.S. Justice Department has joined several whistleblower lawsuits against Indivior Plc and Reckitt Benckiser Group PLC, alleging that the drugmakers improperly marketed the opioid addiction treatment Suboxone.

Select another date: